A Study of Intravenous Acetaminophen for Small Bowel Obstruction

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT05878015
Phase
PHASE4
Status
Enrolling By Invitation

Conditions

  • Small Bowel Obstruction

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Acetaminophen — DRUG
    1000mg intravenous every 6 hours on day 1 and day 2. 1000mg intravenous every 8 hours on day 3 as needed.

Study Details

The purpose of this study is to compare IV Acetaminophen for pain control to the usual care with opioids in patients admitted for small bowel obstruction.

Key Dates

Start date
Oct 11, 2023
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
18 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: IV Acetaminophen Group
    Subjects presented to emergency department (ED) and diagnosed with small bowel obstruction which receive IV acetaminophen
  • No Intervention: Usual Care Group
    Subjects presented to emergency department (ED) and diagnosed with small bowel obstruction will receive intravenous opioids per their provider's choice as standard of care.

Primary Outcome Measure

Resolution of small bowel obstruction [ Time Frame: 3 days ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic FloridaJacksonvilleFlorida32224-

Find similar trials in Jacksonville, FL